GHK-Cu · BPC-157 · Thymosin Beta-4 research vial

Body Composition & Wellness

GHK-Cu · BPC-157 · Thymosin Beta-4

Research-only peptide supplied as a lyophilized vial for qualified laboratory handling.

Per-vial price

$100.00

Add to Order

Research Context

What researchers are studying

This research-stack preparation combines three constituent peptides — GHK-Cu, BPC-157, and Thymosin Beta-4 — supplied together in a single lyophilized vial. Each component has been characterized separately in published research, and the combined preparation is widely discussed in research forums investigating dermal copper-peptide signaling, soft-tissue repair markers, and actin-binding signaling on skin-health pathways in preclinical models.

Researchers studying combined peptide protocols in connective-tissue and barrier-signaling research order this preparation as a single-vial format. Published work on the constituent peptides covers downstream markers of collagen-bound copper signaling, mucosal repair response, and cellular migration in rodent and cell-culture systems.

For research laboratory handling only.

Handling & Storage

Standard research handling

  • Lyophilized blended preparation. Store cool and dry unopened; refrigerate at 2–8 °C.
  • Reconstitute with bacteriostatic water (3 mL) before laboratory handling.
  • Refrigerate after reconstitution and protect from light. Avoid repeated freeze-thaw cycles.

Green Chemistry

Our sourcing commitments

Verified Synthesis Partners

Sourced from established peptide manufacturers operating under GMP-aligned quality frameworks.

Batch-Level Third-Party Validation

Every batch undergoes independent purity and identity testing before dispatch.

Controlled Cold-Chain Handling

Lyophilised preparations are handled and shipped under controlled temperature conditions.

Responsible Packaging

Packaging materials selected for minimal environmental footprint; vials and outer materials are recyclable.

This product is supplied for research use only (RUO). It is not approved for human use or any therapeutic indication.

Certificate of Analysis

Per-lot testing reports

Each lot is independently tested by a third-party laboratory before release. Per-lot Certificates of Analysis are published for every batch of this preparation and made available as downloadable PDFs.

  • Lot White Cap·Tested 2026-07-20·Freedom Diagnostics

    Lot QC for the GLOW 70 mg research preparation (blend of GHK-Cu, BPC-157, and Thymosin Beta-4). Identity of each constituent peptide confirmed by LC-MS on the per-lot sheet — reported component amounts: GHK-Cu 48.65 mg, BPC-157 9.47 mg, Thymosin Beta-4 10.63 mg; appearance: blue lyophilized powder. The 99.64% purity result is a single-lot analytical measurement on a formulated mixture; the PDP does not make a product-level purity marketing claim for this blend.

This preparation is supplied for research use only (RUO). It is not approved for human use or any therapeutic indication.

Quality Standards

Sourced to research-grade standards

Sourced to research-grade standards. Each batch is handled under controlled conditions and verified by third-party testing before shipment.

For research use only. Age 21+ acting on behalf of a qualified laboratory, institution, or business.